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Article focus
  We explored the technical feasibility of 
DcE-MRI near total hip arthroplasty (Tha) 
hardware.
  We hypothesised that the perfusion index 
Ktrans is higher for metal-on-metal (MoM) 
implants than for metal-on-polyethylene 
implants.
Key messages
  DcE-MRI near Tha hardware is feasible 
using fast spin echo pulse sequences.
  The highest Ktrans values were found in 
women with MoM implants.
Strengths and limitations
  This is the first time DcE-MRI has been 
performed near Tha hardware in 
humans.
  It was not possible to measure the arterial 
input function.
  Small patient numbers limit the interpre-
tation of data.
perfusion MRI in hips with metal-on-
metal and metal-on-polyethylene total 
hip arthroplasty
a pIloT STuDy
Objectives
Hips with metal-on-metal total hip arthroplasty (MoM THA) have a high rate of adverse 
local tissue reactions (ALTR), often associated with hypersensitivity reactions. Dynamic con-
trast-enhanced magnetic resonance imaging (Dce-MRI) measures tissue perfusion with the 
parameter Ktrans (volume transfer constant of contrast agent). our purpose was 1) to evalu-
ate the feasibility of Dce-MRI in patients with THA and 2) to compare Dce-MRI in patients 
with MoM bearings with metal-on-polyethylene (Mop) bearings, hypothesising that the per-
fusion index Ktrans in hips with MoM THA is higher than in hips with Mop THA.
Methods
In this pilot study, 16 patients with primary THA were recruited (eight MoM, eight Mop). 
Dce-MRI of the hip was performed at 1.5 Tesla (T). For each patient, Ktrans was computed 
voxel-by-voxel in all tissue lateral to the bladder. The mean Ktrans for all voxels was then cal-
culated. These values were compared with respect to implant type and gender, and further 
correlated with clinical parameters.
Results
There was no significant difference between the two bearing types with both genders com-
bined. However, dividing patients by THA bearing and gender, women with MoM bearings 
had the highest Ktrans values, exceeding those of women with Mop bearings (0.067 min−1 
versus 0.053 min−1; p-value < 0.05) and men with MoM bearings (0.067 min−1 versus 0.034 
min−1; p-value < 0.001). considering only the men, patients with MoM bearings had lower 
Ktrans than those with Mop bearings (0.034 min−1 versus 0.046 min−1; p < 0.05).
Conclusion
Dce-MRI is feasible to perform in tissues surrounding THA. Females with MoM THA show 
high Ktrans values in Dce-MRI, suggesting altered tissue perfusion kinematics which may 
reflect relatively greater inflammation.
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Introduction
Total hip arthroplasty (Tha) with metal-on-metal (MoM) 
bearings was reintroduced in the late 1980s. at that time, 
MoM Tha was hypothesised to minimise wear and convey 
longer survivorship than standard metal-on-polyethylene 
(Mop) Tha. although small diameter femoral head MoM 
Thas and certain designs of hip resurfacing have indeed 
done well in large clinical series and registries, large diam-
eter femoral head (> 36 mm) MoM Thas have had high 
rates of adverse local tissue reactions (alTR) and revi-
sions.1-4 unfortunately, it is not clear which of these 
hundreds of thousands of patients’ Thas are at risk to fail.
Ideally, these alTRs should be diagnosed prior to 
significant soft-tissue damage developing. Recent patho-
logical analyses of these alTRs, as well as associated pseu-
dotumours, reveal that the underlying physiology is of a 
hypersensitivity reaction associated with regional hyper-
vascularity.5 at this time there are no validated, definitive 
prognostic tests that can predict alTR. Most commonly, 
the investigation includes radiological imaging (MRI), 
computed tomography (cT), ultrasound (uS) and metal 
ion level testing at the time of clinical presentation. 
however, the radiological findings may be non-specific 
and the findings may not correlate with clinical severity or 
significance.3,6 Because of the associated hypervascular 
response with alTR, a potential prognostic test is dynamic 
contrast-enhanced MRI (DcE-MRI). This technique 
involves rapid, repeated imaging before, during and after 
intravenous injection of a gadolinium-based contrast 
agent7 providing a quantitative index Ktrans, a parameter 
that reflects blood flow and perfusion in tissue. More 
importantly, Ktrans has proven useful for assessing vascu-
lature and inflammation, as well as predicting the future 
course of some microvessel-dependent diseases.8-11 To 
our knowledge, Ktrans measurements have never been 
performed near human Tha. The purpose of this study 
was, 1) to evaluate the feasibility of Ktrans measurements 
of the peri-articular tissue bed in patients with a Tha and 
2) to compare Ktrans in patients with a MoM bearing ver-
sus Mop, hypothesising that Ktrans in hips with MoM Tha 
is higher than in hips with Mop.
Materials and Methods
The recruitment for this study took place between July 
2007 and May 2010 at the ottawa hospital. Ethical 
approval was obtained from the ottawa hospital Research 
Ethics Board, and the trial was registered on www.clini-
caltrials.gov with registration number NcT00911599. 
The study was designed as level three evidence as sub-
jects were originally recruited as part of a prospective 
randomised study quantifying acetabular bone mineral 
density comparing a monoblock cobalt-chrome large 
head MoM bearing with a standard Mop bearing in pri-
mary Tha.12 This study protocol included the evaluation 
of serum metal ion levels. Inclusion criteria were any 
patient between 45 and 75 years of age who 
had undergone  primary Tha for non-inflammatory 
degenerative joint disease, including osteoarthritis 
(degenerative or post-traumatic), congenital hip dyspla-
sia and avascular necrosis. Exclusion criteria included pre-
vious arthrodesis of the hip, Girdlestone procedure, acute 
fracture of the femoral neck, above-knee amputations, 
significant knee arthritis (including previous total knee 
arthroplasty), evidence of active infection, neurological 
or muscular disease that may adversely affect gait or 
weight-bearing, previous ipsilateral hemi-/total resurfac-
ing, uni/bipolar arthroplasty or Tha. patients with neuro-
pathic joints, a requirement for structural bone grafts, 
documented severe psychiatric disease or a documented 
allergy to cobalt chromium molybdenum were also 
excluded from participation.
at the time of this study, 36 of the 50 randomised 
patients had minimum two-year follow-up and of this 
group, two were deceased, one had renal failure, one 
had a fracture and two had undergone a revision, leaving 
30 patients eligible for the study. all of these patients 
were contacted by mail and 24 patients agreed to partici-
pate. Three of these patients were unreachable to book 
the MRI and three patients changed their minds citing 
claustrophobia, leaving 18 patients that had imaging 
completed. Due to poor image quality, two of the 
patients who had the MRI were excluded. The poor 
images were likely to be due to excessive movement dur-
ing the image acquisition.
From this cohort, 16 asymptomatic patients were 
recruited with a mean age at MRI of 65 years (standard 
deviation (sd) 6) (55 to 74). Seven (44%) of the patients 
were males. of the seven male patients, five had a MoM 
Tha and two a Mop Tha. of the nine females, three had a 
MoM Tha and six a Mop. The body mass index (BMI) of 
the patients was 28.4 kg/m2 (sd 4.7) (23 to 38). The MRIs 
were performed between october 2011 and august 2012, 
on average 3.6 years (sd 0.7) (2.4 to 4.7) after arthroplasty 
implantation. There were eight patients in each group 
of large head MoM Tha (BFh, Microport, Memphis, 
Tennessee) and Mop Tha (lineage shell, Microport). The 
median femoral head sizes were 48 mm (40 to 50) and 
28 mm (28 to 36) for MoM and Mop, respectively. prior to 
surgery, all patients had filled out a questionnaire with the 
Western ontario and McMaster universities arthritis index 
(WoMac) and the university of california at los angeles 
(ucla) activity score. all patients repeated the question-
naires two years after surgery. In addition, serum cobalt 
and chromium levels had been taken at the two-year mark. 
peripheral blood was collected, by venipuncture of the 
median cubital vein, into 6 mltrace-element evacuated 
plastic tubes with clot activator (BD Diagnostics, Franklin 
lakes, New Jersey). The blood was mixed immediately 
with the additive by gently inverting the tubes five times, 
allowed to clot for 30 minutes at room temperature, 
and centrifuged for ten minutes at 1600 × g at 4°c. The 
serum was transferred into 8 ml polypropylene screw-cap 
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tubes (Sarstedt Inc., Saint-léonard, Quebec) using a poly-
ethylene plastic transfer pipette (vWR, Mississauga, 
ontario), and frozen/stored at -20°c. concentrations of 
co and cr were measured by inductively coupled plasma 
mass spectrometry (london laboratory Services Group, 
london health Sciences centre, london, ontario, 
canada). corrections for co and cr contamination origi-
nating from the containers were not required.
MRI was performed on a 1.5 Tesla (T) scanner 
(Magnetom Symphony; Siemens aG, Medical Solutions, 
Erlangen, Germany). Before DcE-MRI, standard ana-
tomic imaging was performed with T1-weighted fast 
spin echo (FSE), and short tau inversion recovery (STIR) 
sequences in the axial, coronal and sagittal planes. Metal 
artefact reduction strategies were incorporated into the 
protocol, including increased bandwidth, use of fast 
spin echo as opposed to spin echo or gradient recalled 
echo sequences, minimisation of the echo time, and 
minimising voxel size by increasing the frequency 
encode direction steps. In addition, the number of 
averages and phase oversampling was increased in order 
to recover some of the signal that may be lost by the 
artefact minimisation protocol. The parameters for 
T1-weighted FSE were bandwidth = 385 hz/pixel, TR = 
649 ms, TE = 9.1 ms, acquisition matrix = 448 x 224, 
number of averages = 2. The parameters for STIR were 
bandwidth = 395 hz/pixel, TR = 4500 ms, TE = 34 ms, 
acquisition matrix = 384 x 211, number of averages = 2, 
and inversion time = 155 ms.
DcE-MRI was performed using the “Bookend” method 
developed in 1999 by cron, Santyr and Kelcz.13 Rapid, 
repeated, T1-weighted imaging with injection of contrast 
agent was flanked in time by two “Bookend” spin-lattice 
relaxation time (T1) inversion recovery measurements. In 
other words, a T1 measurement was performed, fol-
lowed by dynamic imaging with contrast, followed by a 
second T1 measurement. The two T1 measurements 
served to convert the dynamic signal-versus-time to gado-
linium concentration- versus -time.13 FSE was used for all 
pulse sequences of the Bookend method, in order to 
minimise metal artefacts. FSE parameters were: echo 
train length = 7, bandwidth = 349 hz/pixel, echo time = 
6.8 ms, number of slices = 16, slice thickness = 6 mm, 
gap between slices = 1.5 mm, field of view = 22 cm, and 
matrix size = 128 x 128. The images were acquired in 
the axial plane with slices prescribed between the level 
of the lesser trochanter and the acetabular roof. Each T1 
measure ment was performed with repetition time = 
8000 ms and an inversion pulse with inversion times = 
500, 1000, and 3000 ms. T1 was computed for each 
voxel by fitting an exponential recovery curve. The 
dynamic imaging with contrast was performed with 
repetition time = 865 ms, no inversion pulse, temporal 
resolution = 7.8 s, gadolinium contrast agent dose =  
0.1 mmol/kg (Magnevist; Bayer, Berlin, Germany), 
injection rate = 2.5 cc/sec, and duration of DcE-MRI =  
4 min. The total scan time of the Bookend method was 
11 minutes.
For each voxel, a gadolinium concentration-versus-
time curve was estimated from the two T1 measurements 
and the dynamic signal-versus-time curve was estimated 
using the Bookend method.13 contrast agent accumula-
tion (in millimolar) was calculated for each voxel using 
the end of the concentration-versus-time curve. The con-
centration-versus-time data were then analysed voxel-by-
voxel with nordicIcE software (NordicNeurolab, Bergen, 
Norway) using the Extended Tofts Model to generate 
three-dimensional maps of Ktrans.14 For this modeling, a 
population-based arterial input function was used.15 
Example DcE-MRI data are shown in Figures 1 and 2.
a single, mean Ktrans value for the entire peri- 
prosthetic tissue bed (including peri-prosthetic soft tissue, 
muscle and fat) lateral to the bladder was calculated for 
each patient. Image review was performed by a fellow-
ship-trained musculoskeletal radiologist (KR) with nine 
years of experience. The radiologist drew a rectangular 
region of interest (RoI) on each of the 16 DcE-MRI axial 
slices. The height (anterior-posterior direction) of the RoI 
spanned the entire image (22 cm). The position and width 
of the RoI in the left-right direction were chosen to include 
all tissue in the image lateral to the bladder (including 
peri-prosthetic soft tissue, muscle and fat), excluding the 
bladder and any tissue anterior or posterior to it. The 
mean Ktrans value (excluding zero values, characteristic 
of those voxels highly affected by the metal artefact) for all 
voxels in all slices within these RoIs was then computed. 
considering only muscle, contrast agent accumulation 
was estimated to be 0.10 ± 0.02 mM, with Ktrans values 
0.04 ± 0.01 min−1, in line with the literature.16,17
SpSS software (IBM corp, armonk, New york.) was 
used for statistical analysis. The Independent samples 
t-test (student t-test) was used to compare parameters 
between hips with MoM and Mop bearings. Normal dis-
tribution was tested using the Kolmogorov-Smirnov test. 
correlation coefficients between Ktrans values and clini-
cal parameters including metal ion concentration in the 
serum, BMI, age, WoMac and ucla (pre- and post-
operative) were calculated using the pearson test. We 
assumed statistical significance at p-value < 0.05. 
correlation coefficient of 0.20 to 0.39 was defined as a 
weak, 0.40 to 0.59 as a moderate, 0.6 to 0.79 as a strong, 
and ≥ 0.8 as a very strong correlation.
Results
considering all Ktrans data (all tissues, both genders 
combined), there was no difference between the two 
bearing types (mean Ktrans value for MoM hips = 0.046 
min−1 versus 0.051 min−1 for Mop hips; p > 0.05) (Table I). 
a significant correlation between Ktrans values and tita-
nium concentration in the serum was observed 
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Example dynamic contrast enhanced (DcE)-MRI dataset for one patient. a) one slice of a high-resolution T1-weighted FSE sequence (standard-of-care anatomic 
imaging performed before DcE-MRI). b) Same slice location with one image of the DcE-MRI sequence. Small yellow box shows an region of interest (RoI) in 
muscle. large cyan-coloured box shows the whole-tissue RoI used for mean Ktrans calculations. c) Example concentration-vs-time curve in the muscle RoI. d) 
Resultant Ktrans map, in units of min−1. The mean Ktrans value (counting non-zero values only), standard deviation, and standard error for this patient were 
0.062, 0.049, and 0.00015, respectively.
(R  =  0.760, p = 0.011), but not with chromium and 
cobalt serum levels (p > 0.05). chromium and cobalt 
serum levels were significantly higher in patients with 
MoM Tha than in patients with Mop Tha (p < 0.01), but 
titanium levels were not. correlation of Ktrans versus 
BMI, age, WoMac or ucla (pre- or post-operative) was 
not significant (p > 0.05), considering all patients com-
bined or by gender subanalysis.
Gender subanalysis did, however, reveal that males with 
MoM bearings had significantly lower Ktrans values than 
those with Mop bearings (0.034 min−1 versus 0.046 min−1; 
p = 0.019) whereas females with MoM bearings had signifi-
cantly higher Ktrans values than those with Mop bearings 
(0.067 min−1 versus 0.053 min−1; p = 0.024) and higher 
than males with MoM bearings (0.067 min−1 versus 0.034 
min−1; p = 0.000) (Fig. 3). There was no significant differ-
ence in serum concentration of chromium and cobalt and 
in clinical scores in MoM Tha between men and women 
(p > 0.05). None of the patients was diagnosed with alTR 
and none underwent revision within two years of surgery.
Discussion
understanding the pathological mechanism of implant 
failure remains a challenge. Several factors may influence 
this failure, including implant positioning, implant mate-
rial, patient activity and the biology of the host.18 More 
importantly, the fact that some patients have failure of 
their joint arthroplasties with no measurable, or minimal, 
wear while others with significant wear have minimal to 
no host response would indicate that the host response 
to implant wear debris is key variable.19 consequently, 
gaining a better understanding of the pathological mech-
anisms that may influence the development of an inflam-
matory reaction in the presence of a Tha is critical in the 
development of screening and diagnostic tools for alTR. 
When looking at failed MoM Tha, Willert et al20 described 
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an aseptic, lymphocyte-dominated, vasculitis-associated 
lesion (alval), indicating a delayed hypersensitivity reac-
tion. It has also been shown that Tha has a shorter lifes-
pan in patients whose skin tests positive for sensitisation 
to implant components.21 To our knowledge, this is the 
first report of DcE-MRI data in patients with a Tha. our 
pilot study has shown that MRI is achievable using a fast 
spin echo sequence for the DcE-MRI instead of the con-
ventional gradient echo sequence, which would be 
prone to significant metal artefact.22-24
table I. Demographics, clinical scores, blood analyses and Ktrans values in subjects with metal-on-metal (MoM) bearing compared with metal-on- polyethylene 
(Mop) bearing, divided by gender
parameter 
hips (patients)
MoM Mop
total
8 (8)
Men
5 (5)
Women
3 (3)
total
8 (8)
Men
2 (2)
Women
6 (6)
Ktrans (min−1) 0.046 (0.018)  
(0.025 to 0.071)
0.034 (0.005)  
(0.025 to 0.037)†
0.067 (0.005)  
(0.062 to 0.071)
0.051 (0.007)  
(0.041 to 0.061)
0.046 (0.002)  
(0.040 to 0.047)
0.053 (0.008)  
(0.041 to 0.061)
age (yrs) 64.5 (6.2)  
(55 to 72)
65.6 (6.3)  
(55 to 72)
62.7 (6.8)  
(55 to 68)
65.3 (5.3)  
(56 to 74)
63.0 (1.4)  
(62 to 64)
66.0 (6.0)  
(56 to 74)
BMI (kg/m2) 29.1 (4.2)  
(25.0 to 34.4)
29.7 (5.3)  
(25.0 to 34.4)
28.3 (3.0)  
(25.8 to 31.6)
27.7 (5.8)  
(23.3 to 37.9)
24.6 (1.3)  
(23.7 to 25.5)
29.0 (6.6)  
(23.3 to 37.9)
Baseline WoMac 54.7 (23.9)  
(11.3 to 87.9)
55.4 (15.5)  
(37.3 to 78.0)
53.6 (38.9)  
(11.3 to 87.9)
49.2 (14.6)  
(26.3 to 70.3)
40.6 (0.6)  
(40.2 to 41.0)
52.1 (16.1)  
(26.3 to 70.3)
Baseline ucla 3.7 (2.0) (2 to 7) 3.0 (1.4) (2 to 5) 4.7 (2.5) (2 to 7) 4.6 (2.5) (3 to 6) 4.5 (2.1) (3 to 6) 4.7 (1.5) (3 to 6)
Follow-up WoMac 91.8 (9.5)  
(78.1 to 100)
88.2 (10.5)  
(78.1 to 100)
97.9 (2.8)  
(94.8 to 100)
86.0 (13.9)  
(60.0 to 100)
89.1 (0.7)  
(88.5 to 89.6)
85.0 (16.3)  
(60.0 to 100)
Follow-up ucla 7.1 (0.8) (6 to 8) 7.2 (0.8) (6 to 8) 7.0 (1.0) (6 to 8) 6.6 (1.2) (5 to 8) 7.5 (0.7) (6 to 8) 6.3 (1.2) (5 to 8)
Titanium serum 
concentration (mg/ml)
2.9 (3.1)  
(1.1 to 7.4)
1.4 (0.4)  
(1.1 to 1.8)†
7.4 2.7 (0.6)  
(1.7 to 3.4)
2.95 (0.32)  
(2.73 to 3.18)
2.55 (0.69)  
(1.76 to 3.40)
chromium serum 
concentration (mg/ml)
1.9 (1.2)  
(1.0 to 4.4)*
2.0 (1.6)  
(1.0 to 4.4)
1.7 (0.8)  
(1.0 to 2.5)
0.4 (0.4)  
(0.1 to 1.0)
0.24 (0.06) 
(0.19 to 0.28)
0.44 (0.45)  
(0.06 to 1.21)
cobalt serum 
concentration (mg/ml)
3.6 (2.6)  
(0.8 to 8.4)*
4.5 (2.9)  
(1.4 to 8.4)
2.3 (1.9)  
(0.8 to 4.4)
0.3 (0.1)  
(0.2 to 0.5)
0.29 (0.11) 
(0.22 to 0.37)
0.27 (0.12)  
(0.17 to 0.47)
*Significant difference between MoM and Mop bearing
†Significant difference between gender with MoM bearing
values of continuous parameters are expressed as mean and standard deviation with range in parentheses; BMI, body mass index; WoMac, Western ontario 
McMasters universities osteoarthritis index; ucla, university of california, los angeles
Metal-on-metal THA Metal-on-polyethylene THA
Female Male Female Male
0.15 min-1
0.00 min-1
0.071
0.062
0.068
0.025
0.033
0.036
0.037
0.036
0.049
0.058
0.049
0.058
0.041
0.061
0.045
0.047
Fig. 2
all Ktrans maps (one slice shown per patient), grouped by Tha implant type and gender. The maps have been cropped to show only the regions lateral to the 
bladder which were used for computations. Mean Ktrans value (in units of min−1) is displayed under each map. For each patient, the standard deviation across 
all Ktrans values was approximately 0.8 times the mean Ktrans value. The standard error was approximately 0.002 times the mean Ktrans value.
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Different imaging techniques have been applied to 
evaluate for alTR, but none of these techniques can dif-
ferentiate between incidental, asymptomatic changes 
and symptomatic, more clinically significant changes that 
may be precursors to joint failure. conventional radio-
graphs are insensitive for diagnosing alTR.25 By applying 
a metal artefact reduction sequence (MaRS), MRI of diag-
nostic quality is feasible in hips with Tha. The typical 
finding in hips with alTR is a complex peri-prosthetic 
mass or collection, often with heterogeneous fluid 
 signal.26 This collection often communicates with the hip 
joint but can extend into the surrounding muscles, inter-
muscular planes, tendon sheaths and subcutaneous 
fat.25,26 a grading system for MRI findings has been intro-
duced, but fails to differentiate between benign and 
aggressive lesions or to determine risk of progression.27 
on ultrasound, alTR has been described as a solid or 
cystic mass or a complex fluid collection.28
In this study we found that female patients with a MoM 
bearing have a significantly higher level of perfusion, as 
measured with DcE-MRI, compared with the Mop group. 
When looking at the clinical outcome of female patients 
with MoM Tha, pseudotumours, metal-bearing compli-
cations, aseptic loosening, and prosthesis revision are sig-
nificantly higher compared with male patients.29,30 It has 
been postulated that these increased problems in women 
are due to wider range of hip joint motion and subse-
quently more frequent impingement, or higher incidence 
of metal allergy caused by wearing jewellery.30 although 
there is most likely a multifactorial aetiology to these poor 
outcomes (i.e. fibrous fixation of the implant, soft-tissue 
irritation, reaction to wear debris), female gender certainly 
stands out. looking at patients with MoM Tha in this 
study, women had Ktrans values which were nearly 
double those of men, possibly indicating a different host 
response to a MoM bearing. all Thas, regardless of type, 
may have some level of inflammatory response or per-
haps mild alteration in perfusion kinetics of soft tissues. 
There are two variables that determine the degree of 
response: gender and Tha type. It is therefore possible 
that the inflammatory profile, from lowest to greatest, 
is ranked 1) Male MoM 2) Mop (equal for both genders) 
3) Female MoM. The pathway for developing soft-tissue 
reactions is not fully elucidated, and is likely a function of 
variable implant inflammatory profiles as well as gender-
specific physiology. Indeed, gender differences have been 
reported for cerebral and cardiac perfusion measured 
with MRI, with 13% to 20% higher values in women, simi-
lar to what we found in Mop Tha patients (11% higher 
Ktrans values in women).31,32
With the numbers available, we were unable to iden-
tify a correlation between Ktrans and WoMac scores, 
ucla scores, cobalt ion levels, or chromium ion levels. 
This may not be surprising given that alTR has not been 
found to correlate with pain or metal ion serum 
 levels.3,26,33-35 although Ktrans did not correlate with 
cobalt and chromium levels, it did correlate with titanium 
levels (R = 0.760, p = 0.011). This suggests that titanium 
may have a greater inflammatory profile, or may be of 
greater relevance than the other ions in the study of ion-
related soft-tissue reactions.
an important limitation of this study was the small 
number of patients in each group. The patients were ran-
domised, in an effort to minimise selection bias. This 
work was constructed as a pilot study, however, and the 
fact that significant differences were found despite the 
small number demonstrates the exciting potential of this 
imaging technique in diagnosing alTR. It is unclear if any 
of these patients will eventually go on to have failure of 
their joint arthroplasty and more long-term follow-up 
of this patient cohort is needed. The absent difference of 
Ktrans values between hips with MoM and hips with Mop 
bearing cannot be proved with this sample size, as a 
type II error cannot be excluded.
DcE-MRI images suffered from metal artefacts imme-
diately adjacent to the implant, although this did not sig-
nificantly affect image quality in the surrounding tissues 
(Fig. 1). another limitation was that we were unable to 
obtain individual arterial input functions. This is because 
spin echo sequences are particularly sensitive to inflow 
effects, making it difficult to obtain reliable DcE-MRI 
curves in blood.36 only one hip was scanned per patient. 
It was not feasible to scan both simultaneously as this 
would have increased the field of view and required a sig-
nificant increase in scan time or a reduction in resolution. 
however, doing a separate scan of the contralateral side, 
or native hip without Tha, would have provided an 
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Fig. 3
Ktrans values in hips with a total hip arthroplasty, divided by bearing and 
gender. Error bars show 95% confidence intervals. Ktrans values are signifi-
cantly increased in females with metal-on-metal (MoM) bearing compared 
with males with MoM bearing and females with metal-on-polyethylene (Mop) 
bearing. Males with MoM bearing show significantly lower Ktrans values than 
males with Mop bearing.
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internal reference for each subject, and will be consid-
ered for future projects beyond this pilot study.
This study has shown the feasibility of a novel DcE-
MRI technique for evaluation of tissue surrounding Tha. 
higher Ktrans values measured with DcE-MRI were found 
in female patients with MoM Tha, indicating high tissue 
perfusion. This may reflect gender differences or under-
lying adverse tissue inflammatory reaction, which may be 
a precursor to tissue damage. our findings have potential 
future clinical and research applications for identifying 
and stratifying patients of particular gender and/or with 
various Tha types who may be at increased risk for joint 
failure due to tissue hypersensitivity reactions.
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